feed,title,long_url,short_url
Benzinga,"Analysts Consider CRISPR Therapeutics' Blood Disorder Trial Data Encouraging, Impressive",https://benzinga.com/analyst-ratings/analyst-color/22/06/27679146/analysts-consider-crispr-therapeutics-blood-disorder-trial-data-encouraging-impress,https://bit.ly/3xJTIvE
